KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Gilead Sciences (GILD) EPS (Basic) (2016 - 2025)

Historic EPS (Basic) for Gilead Sciences (GILD) over the last 17 years, with Q3 2025 value amounting to $2.46.

  • Gilead Sciences' EPS (Basic) rose 14600.0% to $2.46 in Q3 2025 from the same period last year, while for Sep 2025 it was $6.51, marking a year-over-year increase of 641000.0%. This contributed to the annual value of $0.38 for FY2024, which is 9145.79% down from last year.
  • According to the latest figures from Q3 2025, Gilead Sciences' EPS (Basic) is $2.46, which was up 14600.0% from $1.57 recorded in Q2 2025.
  • Gilead Sciences' 5-year EPS (Basic) high stood at $2.46 for Q3 2025, and its period low was -$3.34 during Q1 2024.
  • In the last 5 years, Gilead Sciences' EPS (Basic) had a median value of $1.21 in 2021 and averaged $0.98.
  • As far as peak fluctuations go, Gilead Sciences' EPS (Basic) soared by 395000.0% in 2023, and later plummeted by 51234.57% in 2024.
  • Over the past 5 years, Gilead Sciences' EPS (Basic) (Quarter) stood at $0.3 in 2021, then surged by 337.6% to $1.31 in 2022, then decreased by 13.39% to $1.13 in 2023, then increased by 25.95% to $1.43 in 2024, then soared by 72.14% to $2.46 in 2025.
  • Its EPS (Basic) stands at $2.46 for Q3 2025, versus $1.57 for Q2 2025 and $1.06 for Q1 2025.